Hemab Therapeutics Holdings, Inc. · NASDAQ:COAG

AI DEN-MAB LLC reported a 10.40% stake in Hemab Therapeutics Holdings, Inc. (Schedule 13D)

Event May 4, 2026 · Filed May 11, 2026

AI DEN-MAB LLC reported a 10.40% stake in Hemab Therapeutics Holdings, Inc., 4,876,344 shares, with active intent on May 4, 2026. Filed May 11, 2026 (Schedule 13D).

Stake
10.40%
Shares
4,876,344
Intent
Active
What changed
Crossed above 5%
Filed together
5 holders

The filing in full

HolderStakeShares
AI DEN-MAB LLC10.40%4,876,344
Access Industries Holdings LLC10.40%4,876,344
AI Biotechnology LLC10.40%4,876,344
Access Industries Management LLC10.40%4,876,344
Len Blavatnik10.40%4,876,344

Source

View original at SEC

Related